Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.89
+0.01 (0.15%)
At close: Sep 16, 2026, 4:00 PM EDT
6.89
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Entrada Therapeutics Employees
Entrada Therapeutics had 152 employees as of December 31, 2025. The number of employees decreased by 31 or -16.94% compared to the previous year.
Employees
152
Change (1Y)
-31
Growth (1Y)
-16.94%
Revenue / Employee
$30,829
Profits / Employee
-$1,090,645
Market Cap
248.43M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | -31 | -16.94% |
| Dec 31, 2024 | 183 | 24 | 15.09% |
| Sep 30, 2024 | 177 | 27 | 18.00% |
| Jun 30, 2024 | 168 | 37 | 28.24% |
| Mar 31, 2024 | 160 | 30 | 23.08% |
| Dec 31, 2023 | 159 | 29 | 22.31% |
| Sep 30, 2023 | 150 | 26 | 20.97% |
| Jun 30, 2023 | 131 | 9 | 7.38% |
| Mar 31, 2023 | 130 | 16 | 14.04% |
| Dec 31, 2022 | 130 | 16 | 14.04% |
| Sep 30, 2022 | 124 | 26 | 26.53% |
| Jun 30, 2022 | 122 | 44 | 56.41% |
| Mar 31, 2022 | 114 | 36 | 46.15% |
| Dec 31, 2021 | 114 | - | - |
| Sep 30, 2021 | 98 | - | - |
| Jun 30, 2021 | 78 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Invivyd | 122 |
| Foghorn Therapeutics | 106 |
| Alector | 103 |
| Lineage Cell Therapeutics | 77 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
| Anavex Life Sciences | 34 |
TRDA News
- 6 days ago - Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program - GlobeNewsWire
- 7 days ago - Entrada Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 14 days ago - Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Entrada Therapeutics price target raised to $11 from $10 at Roth Capital - TheFly
- 6 weeks ago - Entrada Therapeutics reports Q2 EPS ($1.01), consensus ($1.04) - TheFly
- 6 weeks ago - Entrada Therapeutics Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Entrada Therapeutics Earnings release: Q2 2026 - Filings
- 6 weeks ago - Entrada Therapeutics Quarterly report: Q2 2026 - Filings